FIELD: medicine. SUBSTANCE: method involves taking whole blood samples from patient, separating lipide fraction in which phosphatidylinosites level is determined using horizontal flow chromatography method. The value being equal to 6.0-6.5 nmole of phosphatidylinosites phosphorus per 1 mg of protein, glandular endometrial hyperplasia diagnosis is set. The value being equal to 4.2-5.0 of phosphorus per 1 mg of protein, atypical hyperplasia diagnosis is set. The value being equal to 1.2-3.3 of phosphorus per 1 mg of protein, endometrial carcinoma diagnosis is set. EFFECT: enhanced accuracy in setting diagnosis.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING ENDOMETRIAL HYPERPLASIA TREATMENT EFFECTIVENESS | 1993 |
|
RU2054184C1 |
METHOD FOR DIAGNOSING ADENOMYOSIS | 1993 |
|
RU2054182C1 |
DIFFERENTIAL METHOD FOR DIAGNOSING HYPERPLASIA, DYSPLASIA AND CARCINOMA OF THE PROSTATE | 1999 |
|
RU2156977C1 |
METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE | 1999 |
|
RU2151397C1 |
METHOD OF HYPERPLASTIC ENDOMETRIUM PROCESSES DIAGNOSTICS AT HYSTEROMYOMA | 2007 |
|
RU2327164C1 |
METHOD FOR EARLIER DIAGNOSTICS OF BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES | 2000 |
|
RU2190221C2 |
METHOD FOR DIAGNOSTICS OF ENDOMETRIUM PATHOLOGY IN PATIENTS WITH HYSTEROMYOMA | 2007 |
|
RU2334987C1 |
METHOD FOR DIAGNOSING THE CASES OF GLAND CYST HYPERPLASIA | 2000 |
|
RU2199741C2 |
METHOD OF PREDICTING EFFICIENCY OF INTERCOSTAL IMPLANTATION IN MAXILLOFACIAL PATIENTS | 1997 |
|
RU2127885C1 |
METHOD OF TREATING BENIGN HYPERPLASTIC PROCESSES OF FEMALE REPRODUCTIVE SYSTEM | 2011 |
|
RU2471485C1 |
Authors
Dates
1996-02-10—Published
1993-07-07—Filed